Activating mutations of Gs protein in monostotic fibrous lesions of bone
- PMID: 8648511
- DOI: 10.1002/jor.1100140221
Activating mutations of Gs protein in monostotic fibrous lesions of bone
Abstract
Activating mutations of the alpha chain of the heterotrimeric signal transducer Gs disrupt the inherent guanosine triphosphatase activity of the alpha chain, stimulate adenylyl cyclase, and can result in independent cell proliferation. Such mutations are identified in a number of endocrine disorders, including McCune-Albright syndrome, which is a triad of endocrinopathy, café au lait spots, and polyostotic fibrous dysplasia. The mutation in this syndrome is a missense point mutation in exon 8 that results in the substitution of either histidine or cysteine for arginine at position 201. Monostotic fibrous dysplasia is a nonhereditary isolated bone lesion. Other isolated bone lesions that share some cytologic and clinical similarities to fibrous dysplasia are osteofibrous dysplasia and aggressive fibromatosis involving bone. Four cases of monostotic fibrous dysplasia, four cases of aggressive fibromatosis involving bone, and one case of osteofibrous dysplasia were studied to determine if a mutation was present in exon 8 of the alpha chain of Gs. A missense mutation was present in all of the fibrous dysplasias. The other fibrous lesions and uninvolved tissue did not contain a mutation. Somatic activating mutations of Gs differentiate fibrous dysplasia from the other lesions and may be responsible for the loss of control of local proliferation and growth factor expression.
Similar articles
-
Increased proliferation of osteoblastic cells expressing the activating Gs alpha mutation in monostotic and polyostotic fibrous dysplasia.Am J Pathol. 1997 Mar;150(3):1059-69. Am J Pathol. 1997. PMID: 9060842 Free PMC article.
-
Activating mutations of the stimulatory G protein in the McCune-Albright syndrome.N Engl J Med. 1991 Dec 12;325(24):1688-95. doi: 10.1056/NEJM199112123252403. N Engl J Med. 1991. PMID: 1944469
-
Is McCune-Albright syndrome overlooked in subjects with fibrous dysplasia of bone?J Pediatr. 2003 May;142(5):532-8. doi: 10.1067/mpd.2003.153. J Pediatr. 2003. PMID: 12756386
-
Fibrous dysplasia of bone and McCune-Albright syndrome.Best Pract Res Clin Rheumatol. 2008 Mar;22(1):55-69. doi: 10.1016/j.berh.2007.11.004. Best Pract Res Clin Rheumatol. 2008. PMID: 18328981 Review.
-
[Cellular and molecular biology of fibrous dysplasia].Ann Pathol. 2001 Dec;21(6):489-98. Ann Pathol. 2001. PMID: 11910936 Review. French.
Cited by
-
The surgical management of fibrous dysplasia of bone.Orphanet J Rare Dis. 2012 May 24;7 Suppl 1(Suppl 1):S1. doi: 10.1186/1750-1172-7-S1-S1. Epub 2012 May 24. Orphanet J Rare Dis. 2012. PMID: 22640754 Free PMC article.
-
Fibrocartilaginous dysplasia (fibrous dysplasia with extensive cartilaginous differentiation).Pathol Oncol Res. 2006;12(2):111-4. doi: 10.1007/BF02893455. Epub 2006 Jun 24. Pathol Oncol Res. 2006. PMID: 16799714
-
Case report: two-step malignant transformation of a liposclerosing myxofibrous tumor of bone.Clin Orthop Relat Res. 2008 Nov;466(11):2873-7. doi: 10.1007/s11999-008-0362-9. Epub 2008 Jul 8. Clin Orthop Relat Res. 2008. PMID: 18607664 Free PMC article.
-
Osteofibrous dysplasia: a narrative review.J Orthop Surg Res. 2024 Mar 27;19(1):204. doi: 10.1186/s13018-024-04682-3. J Orthop Surg Res. 2024. PMID: 38539216 Free PMC article. Review.
-
Fibrous dysplasia of bone in the McCune-Albright syndrome: abnormalities in bone formation.Am J Pathol. 1997 Dec;151(6):1587-600. Am J Pathol. 1997. PMID: 9403710 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources